Early Ventriculo-peritoneal Shunt in Subarachnoid Patients With External Ventricular Drainage
EarlyVPS
1 other identifier
interventional
100
1 country
1
Brief Summary
Acute hydrocephalus is a common complication following subarachnoid hemorrhage (SAH). Early and emergency insertion of external ventricular drain (EVD) is standard treatment of acute post-SAH hydrocephalus. According to the high risk of infection associated with EVD, the study evaluates the outcome of early EVD conversion to ventriculoperitoneal shunt (VPS) in poor-grade SAH patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2017
CompletedFirst Submitted
Initial submission to the registry
September 23, 2020
CompletedFirst Posted
Study publicly available on registry
September 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedMarch 18, 2022
March 1, 2022
4.1 years
September 23, 2020
March 17, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
rate of ventriculo-peritoneal malfunction
VPS is defined malfunction when signs of hydrocephalus are seen in imaging (CTS or MRI)/clinical findings
3 months
rate of ventricle-peritoneal infection
3 months
Secondary Outcomes (1)
RBC / protein level in CSF association with VPS malfunction
3 months
Study Arms (1)
Early VPS
EXPERIMENTALInterventions
EVD in high grade SAH patients were converted into VPS with 7-10 days of EVD insertion
Eligibility Criteria
You may qualify if:
- patients with SAH and World Federation of Neurosurgeon (WFNS) Grade 4 or 5 and
- patient who underwent ventriculostomy (EVD insertion) within 24 hours of SAH onset.
You may not qualify if:
- patients with Glasgow Coma Scale of (GCS) 3 and fixed non-reactive pupils,
- patients in whom EVD was inserted in the other hospital,
- patients were successfully weaned from EVD with 7-10 days of EVD insertion
- patients who died during hospitalization.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ghaem Hospital, Mashhad University of Medical Sciences
Mashhad, Iran
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neurosurgical Department
Study Record Dates
First Submitted
September 23, 2020
First Posted
September 28, 2020
Study Start
January 1, 2017
Primary Completion
February 1, 2021
Study Completion
March 1, 2021
Last Updated
March 18, 2022
Record last verified: 2022-03